GENERAL21 Sept 2026
Concord Biotech bonus issue sparks rally! Pharma stock jumps 6% on maiden share reward - Top things to know | Stock Market News
Concord Biotech shares jumped nearly 6% on Monday after the company said its board will meet on September 23, 2026, to consider its first-ever bonus share issue for existing shareholders. The stock was trading 5.23% higher at ₹1,572.05 on BSE. A bonus issue hands you extra shares free, without paying anything. Record date details are still awaited, so watch for that update before buying.
Key Statutory Highlights
- Concord Biotech's board will meet on September 23, 2026, to consider declaring bonus equity shares to existing equity shareholders.
- This will be the first time the Gujarat-based pharmaceutical company issues bonus shares to its shareholders.
- The stock was trading 5.23% higher at ₹1,572.05 per share on BSE on Monday, with a market capitalisation of ₹16,446.19 crore.
Actionable Advice for Taxpayers / Founders:If you already hold Concord Biotech shares, wait for the company's record date announcement and confirm with your broker whether your holding makes you eligible for the bonus shares.
Statutory Disclaimer: TaxQue Shorts are AI-assisted editorial briefs for compliance awareness. This brief has not passed every source check; confirm the original notification before acting. This does not constitute formal legal or CA counsel.
TaxQue News Desk
Share: